Details for Patent: 9,669,009

Which drugs does patent 9,669,009 protect, and when does it expire?

Patent 9,669,009 protects SPRITAM and is included in one NDA.

This patent has twenty patent family members in nine countries.

Summary for Patent: 9,669,009

Title:	Rapid disperse dosage form containing levetiracetam
Abstract:	A high dose rapidly dispersing three-dimensionally printed dosage form comprising a high dose of levetiracetam in a porous matrix that disperses in water within a period of less than about 15 seconds is disclosed. Also disclosed are methods of preparing the dosage form and of treating a condition, disease or disorder that is therapeutically responsive to levetiracetam.
Inventor(s):	Jacob; Jules (Yardley, PA), Coyle; Norman (Fort Washington, PA), West; Thomas G. (Lawrenceville, NJ), Monkhouse; Donald C. (Radnor, PA), Surprenant; Henry L. (Phoenixville, PA), Jain; Nemichand B. (Princeton Junction, NJ)
Assignee:	Aprecia Pharmaceuticals Company (Langhorne, PA)
Application Number:	15/095,785
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Device; Dosage form;

Drugs Protected by US Patent 9,669,009

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Aprecia Pharms	SPRITAM	levetiracetam	TABLET, FOR SUSPENSION;ORAL	207958-004	Jul 31, 2015		RX	Yes	Yes						METHOD OF ADMINISTERING LEVETIRACETAM
Aprecia Pharms	SPRITAM	levetiracetam	TABLET, FOR SUSPENSION;ORAL	207958-004	Jul 31, 2015		RX	Yes	Yes						METHOD OF ADMINISTERING LEVETIRACETAM UNDER FASTED CONDITIONS
Aprecia Pharms	SPRITAM	levetiracetam	TABLET, FOR SUSPENSION;ORAL	207958-004	Jul 31, 2015		RX	Yes	Yes						METHOD OF ADMINISTERING LEVETIRACETAM UNDER FED CONDITIONS
Aprecia Pharms	SPRITAM	levetiracetam	TABLET, FOR SUSPENSION;ORAL	207958-001	Jul 31, 2015		RX	Yes	No						METHOD OF ADMINISTERING LEVETIRACETAM UNDER FASTED CONDITIONS
Aprecia Pharms	SPRITAM	levetiracetam	TABLET, FOR SUSPENSION;ORAL	207958-001	Jul 31, 2015		RX	Yes	No						METHOD OF ADMINISTERING LEVETIRACETAM UNDER FED CONDITIONS
Aprecia Pharms	SPRITAM	levetiracetam	TABLET, FOR SUSPENSION;ORAL	207958-001	Jul 31, 2015		RX	Yes	No						METHOD OF ADMINISTERING LEVETIRACETAM
Aprecia Pharms	SPRITAM	levetiracetam	TABLET, FOR SUSPENSION;ORAL	207958-002	Jul 31, 2015		RX	Yes	No						METHOD OF ADMINISTERING LEVETIRACETAM

International Family Members for US Patent 9,669,009

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014228990
Australia	2017202752
Canada	2906029
China	105188849
China	109908355
European Patent Office	2968994
European Patent Office	3431141